🦴

Understanding Ehlers-Danlos Syndromes

May 2, 2025

Ehlers-Danlos Syndromes (EDS)

Overview

  • EDS consists of 13 heritable connective tissue disorders caused by genetic changes.
  • Common features across all types include:
    • Joint hypermobility
    • Skin hyperextensibility
    • Tissue fragility

Key Features

Joint Hypermobility

  • Greater range of motion in joints; can be painless or cause joint instability.
  • Joint instability leads to subluxations, dislocations, sprains, injuries, and pain.
  • Hypermobility varies by type, commonly observed in hands and feet.

Skin Hyperextensibility

  • Skin stretches beyond normal range, measured at forearm.
  • Mild to severe hyperextensibility varies, certain EDS types show more.
  • Other skin symptoms: unusual texture, fragility, thinness, poor wound healing, abnormal scarring.

Tissue Fragility

  • Organs and structures are more vulnerable to damage.
  • Symptoms include easy bruising and poor wound healing.
  • Severe fragility affects skin, blood vessels, organs, eyes, gums, bones.

Types of EDS

  • Hypermobile EDS (hEDS): Most common, generalized joint hypermobility, instability, chronic pain.
  • Classical EDS (cEDS): Fragile skin, atrophic scarring, stretchy skin.
  • Vascular EDS (vEDS): Arterial fragility, organ rupture, extensive bruising.
  • Other types include rare forms with specific genetic mutations and distinct symptoms.

Prevalence

  • hEDS: 1 in 3,100-5,000 (most common).
  • cEDS: 1 in 20,000-40,000.
  • vEDS: 1 in 100,000-200,000.
  • Other types: Less than 1 in 1,000,000.

Causes

  • Variants in genes affecting collagen and connective tissue proteins.
  • Genetic causes of hEDS are unidentified but suggest a dominant inheritance pattern.

Inheritance Patterns

  • Dominant: One copy needed; each child has a 50% inheritance chance.
  • Recessive: Two copies needed, one from each parent.
  • De novo mutations can occur.

Symptoms

  • Symptoms vary by type; common signs include joint hypermobility, pain, fatigue.
  • Other conditions often coexist, such as dysautonomia and mast cell diseases.

Diagnosis

  • Each EDS type has specific clinical diagnostic criteria.
  • Genetic testing confirms diagnosis except for hEDS.
  • hEDS diagnosed through clinical criteria; no genetic test available.
  • Hypermobility spectrum disorders (HSD) considered for symptomatic joint hypermobility not meeting EDS criteria.

Management

  • No disease-specific treatments; symptom-based management.
  • Requires a multi-specialty care team.
  • Individualized care plans.

History

  • Named after Dr. Edvard Ehlers and Dr. Henri-Alexandre Danlos.
  • Classification evolved over time, latest in 2017.
  • 2017 classification includes 13 types, introduces HSD.

Classification

  • Current classification uses descriptive names, no Roman numerals.
  • Research ongoing to identify new genetic variants possibly indicating new EDS types.

Other Information

  • Emphasizes the importance of awareness, support groups, and research.